Literature DB >> 879303

Transmural myocardial perfusion during restricted coronary inflow in the awake dog.

R J Bache, P A McHale, J C Greenfield.   

Abstract

Phasic coronary flow and transmural myocardial perfusion were studied during coronary artery constriction in 10 dogs with electromagnetic flowmeters and hydraulic occluders on the left circumflex coronary artery. Regional blood flow was estimated using left atrial injections of radionuclide-labeled microspheres 9 micron in diameter. During control conditions, 14+/-0.7% of coronary flow occurred in systole and subendocardial (endo) flow exceeded subepicardial (epi) flow in the region of the posterior papillary muscle (endo/epi=1.16). Immediately following partial inflation of the occluder to reduce coronary inflow 39+/-3%, systolic flow was unchanged while diastolic flow fell 42+/-3%, thereby increasing the portion of flow in systole to 22+/-1.4%. At this time blood flow was reduced nearly uniformly across the wall of the left ventricle. When coronary constriction was maintained for 30 s, an additional shift of flow from diastole to systole occurred (systolic flow=29+/-2.3% of total inflow), and transmural perfusion was redistributed from subendocardium to subepicardium (endo/epi=0.37). This redistribution of flow was accompanied by a fall in coronary pressure distal to the occluder, indicating vasodilation of the distal coronary vasculature.

Entities:  

Mesh:

Year:  1977        PMID: 879303     DOI: 10.1152/ajpheart.1977.232.6.H645

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Transmural perfusion gradients distal to various degrees of coronary artery stenosis during resting flow or at maximal vasodilation.

Authors:  D C Warltier; H F Hardman; G J Gross
Journal:  Basic Res Cardiol       Date:  1979 Sep-Oct       Impact factor: 17.165

2.  The effect of coronary flow restriction on the viability of porcine myocardium.

Authors:  G Walterbusch; A Haverich; T Reuter; H G Borst
Journal:  Basic Res Cardiol       Date:  1982 May-Jun       Impact factor: 17.165

3.  Changes in transmural distribution of myocardial perfusion assessed by quantitative intravenous myocardial contrast echocardiography in humans.

Authors:  S Fukuda; T Muro; T Hozumi; H Watanabe; K Shimada; M Yoshiyama; K Takeuchi; J Yoshikawa
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

4.  Effects of dipyridamole on collateral flow and regional myocardial function in conscious dogs with newly developed collaterals.

Authors:  M Fujita; A Mikuniya; D P McKown; M D McKown; D Franklin
Journal:  Basic Res Cardiol       Date:  1990 Mar-Apr       Impact factor: 17.165

Review 5.  Evaluation of the microcirculation: advances in cardiac magnetic resonance perfusion imaging.

Authors:  Amit R Patel; Frederick H Epstein; Christopher M Kramer
Journal:  J Nucl Cardiol       Date:  2008 Sep-Oct       Impact factor: 5.952

6.  Reactive hyperemia following total and subtotal coronary occlusion in the awake dog.

Authors:  M W Sharon; R J Bache
Journal:  Basic Res Cardiol       Date:  1982 Nov-Dec       Impact factor: 17.165

7.  Regional coronary perfusion and bioenergetics in experimental atherosclerosis.

Authors:  R M Zwolak; A B Malik; E S Morrison; R F Scott
Journal:  Am J Pathol       Date:  1980-04       Impact factor: 4.307

Review 8.  Indications for coronary angioplasty in acute myocardial ischemic syndromes.

Authors:  P J de Feyter; P W Serruys; P G Hugenholtz
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

9.  Myocardial infarction following acute occlusion and reperfusion of the septal coronary artery.

Authors:  J L Wilson; D E Netherland; L A Ingram; K B Ramanathan; D M Mirvis
Journal:  Basic Res Cardiol       Date:  1985 Nov-Dec       Impact factor: 17.165

10.  Improvement of left ventricular function after percutaneous coronary intervention in patients with stable coronary artery disease and preserved ejection fraction: Impact of diabetes mellitus.

Authors:  Malgorzata Sikora-Frac; Beata Zaborska; Pawel Maciejewski; Andrzej Budaj; Bronislaw Bednarz
Journal:  Cardiol J       Date:  2019-07-01       Impact factor: 2.737

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.